LXP Faces Merger Suit and 14 Demand Letters; Supplements Proxy Ahead of Oct 26 Vote
LXP sits 38% above its 52-week low of $44.17.
Summary
LXP disclosed a shareholder lawsuit and 14 demand letters challenging the proxy for its $61.20-per-share Brookfield/CPPIB buyout, and voluntarily added supplemental disclosures ahead of the October 26 vote. Deal terms are unchanged.
Key Events · M&A and Partnerships · LXP
-
Merger Suit Filed October 9
Garfield v. Eglin (N.Y. Sup. Ct. Index No. 655801/2026) seeks to enjoin the October 26 shareholder vote and the merger until corrective proxy disclosures are made, and asks that any approval obtained be declared void.
-
Fourteen Demand Letters Received
Law firms claiming to represent shareholders sent 14 demand letters alleging disclosure deficiencies in the preliminary and definitive proxy statements; LXP denies all allegations and says the matters are without merit.
-
Proxy Voluntarily Supplemented
LXP added the financial advisor's comparable-company multiples (First Industrial 20.8x EV/EBITDA, STAG 15.9x), nine precedent transactions at 13.1x-28.0x NTM EBITDA, and a DCF using 15.0x-18.0x exit multiples and 8.1%-9.2% discount rates.
-
Bid History Disclosed
Brookfield's indications rose from $50.00 per share on July 9, 2025 to $55.00, $56.00, $57.25 and $60.00 by June 6, 2026, against the $61.20 merger consideration; no proposal included post-closing employment or equity for the board or executives.
Analysis · LXP · Real Estate & Construction
A shareholder suit filed October 9 seeks to block the October 26 vote on the $61.20-per-share Brookfield/CPPIB buyout until LXP makes corrective disclosures, and 14 law-firm demand letters make the same disclosure-deficiency claims. LXP denies the allegations but supplemented the proxy anyway — adding the full bid history ($50.00 in July 2025 rising to $60.00 in June 2026 before the $61.20 deal) and the financial advisor's comparable multiples and DCF inputs. The economics of the deal are unchanged; the risk is timing, since an injunction or a delayed vote would push back the closing that shareholders are being asked to approve in one week.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LXP was trading at $61.08 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $44.17 to $61.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.